{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:04:44Z","timestamp":1780650284955,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xkme.2026.101347","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:19:53Z","timestamp":1775099993000},"page":"101347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute Interstitial Nephritis Is a Potential Adverse Effect in Inflammatory Bowel Disease Patients Treated With Vedolizumab: A Case Report and Review of the Literature"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6324-8656","authenticated-orcid":false,"given":"William A.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Dasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revanth","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.xkme.2026.101347_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101347_bib2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ecco-jcc\/jjw092","article-title":"An overview of the mechanism of action of the monoclonal antibody vedolizumab","volume":"10","author":"Wyant","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10.1016\/j.xkme.2026.101347_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.xkme.2026.101347_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.xkme.2026.101347_bib5","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ekir.2023.05.004","article-title":"Safety and efficacy of vedolizumab in kidney transplant recipients with Crohn's disease","volume":"8","author":"Busutti","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.xkme.2026.101347_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-016-3394-5","article-title":"Tubulointerstitial nephritis: diagnosis, treatment, and monitoring","volume":"32","author":"Joyce","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2026.101347_bib7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.xkme.2026.101347_bib8","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/ibd\/izac140","article-title":"Renal and urological disorders associated with inflammatory bowel disease","volume":"29","author":"Kumar","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101347_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004836-199709000-00011","article-title":"Omeprazole-induced interstitial nephritis","volume":"25","author":"Yip","year":"1997","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101347_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.ajkd.2017.08.008","article-title":"Interstitial nephritis secondary to vedolizumab treatment in Crohn disease and safe rechallenge using steroids: a case report","volume":"71","author":"Bailly","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.xkme.2026.101347_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-254715","article-title":"Vedolizumab-induced acute interstitial nephritis with failure of steroid prophylaxis on vedolizumab rechallenge","volume":"16","author":"O'Leary","year":"2023","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.xkme.2026.101347_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5414\/CN111029","article-title":"Acute tubulointerstitial nephritis possibly caused by vedolizumab for ulcerative colitis in a kidney transplant recipient: a case report","volume":"100","author":"Ogata","year":"2023","journal-title":"Clin Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2026.101347_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243568","article-title":"Acute interstitial nephritis secondary to vedolizumab","volume":"14","author":"Simpson","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.xkme.2026.101347_bib14","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000788","article-title":"Vedolizumab-induced acute interstitial nephritis in ulcerative colitis","volume":"9","author":"Subhaharan","year":"2022","journal-title":"ACG Case Rep J"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:15:22Z","timestamp":1780647322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2590059526001081"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101347","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Interstitial Nephritis Is a Potential Adverse Effect in Inflammatory Bowel Disease Patients Treated With Vedolizumab: A Case Report and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101347"}}